believe what you want I do not give a dam. but he did say it.
no can do but, he did say it, and not in public.
some investors have direct access to him.
she will no doubt be the fi5rst women prez of the USA and to be soon followed up by the first women prez of the USA to be impeached.
Levitt said do not expect any meaningful change in mPFS.
current pps supports this view
mPFS will not move. need to see OS benefit or a subtype benefit to get fda approval.
they can try based on cardio tox alone but those are long odds
what is taking so long to get gbm PII results? they will be good enough to go for a PIII but that will not save the company.
algem looks like the winner too bad its only at the lab stage.
whip when does the cash run out? how do you like the prospects of a secondary at under $4?
AM is running this company like cash is not a problem, and he is wrong big time.
still long my 10,000
not feeling too good about glemba in bc. hope I am wrong.
AM is burning too much cash chasing too many trials. time is running out.
I recently got lucky with srpt. went long Jan 2018 $55 calls before the FDA approval. plenty of time to sit and wait for a takeout. hoping to turn $2k into $100k.
jays are looking strong
Trump is now toast.
The #$%$ wins!
and the cash keeps going out the door.
if glemba in BC fails its lights out unless they can revive rindo by some miracle.
LONG is bullish on glemba, I see no reason to be. the N on the PII was so small as to be completely meaningless re triple negative outcomes
the rest of the pipeline will not save them.
xeloda historical performance - OS 14.5 mths mPFS 4.1 mths - overall population
Glemba's chances in the overall population are not good. triple negative is the only hope
anyone come across data for xeloda in triple negative patients?
the Glemba PII is so small as to be meaningless in predicting likely success.
assuming that the active control is consistent with historical norms
now that is too funny. rindo anyone?